Statistics

Total Visits

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer57

Select a period of time:

Number of views in the range

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer23

Views

Views
October 20242
November 20241
December 20241
January 20252
February 20252
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore13
United States10
 

Top cities views

Views